LncRNA HCG27 Promotes Glucose Uptake Ability of HUVECs by MiR-378a-3p/MAPK1 Pathway

Abstract

Objective

Gestational diabetes mellitus (GDM) is the most common metabolic disorder during pregnancy. LncRNA HLA complex group 27 (HCG27) plays a crucial role in various metabolic diseases. However, the relationship between lncRNA HCG27 and GDM is not clear. This study aimed to verify a competing endogenous RNA (ceRNA) interaction regulation axis of miR-378a-3p/mitogen-activated protein kinase 1 (MAPK1) regulated by HCG27 in GDM.

Methods

LncRNA HCG27 and miR-378a-3p were detected by RT-qPCR. The expression of MAPK1 in umbilical vein endothelial cells (HUVECs) was detected by RT-qPCR and that in the placenta by Western blotting. To explore the relationship among lncRNA HCG27, miR-378a-3p, MAPK1 and the glucose uptake ability of HUVECs, vector HCG27, si-HCG27, miR-378a-3p mimic and inhibitor were transfected to achieve overexpression and inhibition of HCG27 or miR-378a-3p. The interaction between miR-378a-3p and lncRNA HCG27 or MAPK1 was confirmed by the dual-luciferase reporter assay. Besides, glucose consumption by HUVECs was detected by the glucose assay kit.

Results

HCG27 expression was significantly decreased in both the placenta and primary umbilical vein endothelial cells, while the expression of miR-378a-3p was significantly increased in GDM tissues, and the expression of MAPK1 was decreased in GDM tissues. This ceRNA interaction regulation axis was proved to affect the glucose uptake function of HUVECs. The transfection of si-HCG27 could significantly reduce the expression of the MAPK1 protein. If the MAPK1 overexpression plasmid was transfected simultaneously with si-HCG27 transfection, the reduced glucose uptake in HUVECs resulting from the decrease in lncRNA HCG27 was reversed. MiR-378a-3p mimic can significantly reduce the mRNA expression of MAPK1 in HUVECs, whereas miR-378a-3p inhibitor can significantly increase the mRNA expression of MAPK1. The inhibition of miR-378a-3p could restore the decreased glucose uptake of HUVECs treated with si-HCG27. Besides, overexpression of lncRNA HCG27 could restore the glucose uptake ability of the palmitic acid-induced insulin resistance model of HUVECs to normal.

Conclusion

LncRNA HCG27 promotes glucose uptake of HUVECs by miR-378a-3p/MAPK1 pathway, which may provide potential therapeutic targets for GDM. Besides, the fetal umbilical cord blood and umbilical vein endothelial cells collected from pregnant women with GDM after delivery could be used to detect the presence of adverse molecular markers of metabolic memory, so as to provide guidance for predicting the risk of cardiovascular diseases and health screening of offspring.

Keywords

lncRNA / ceRNA / gestational diabetes mellitus / human umbilical vein endothelial cells

References

[1] SacksDA, HaddenDR, MareshM, et al.. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care, 2012, 35(3): 526-528

[2] PlowsJF, StanleyJL, BakerPN, et al.. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci, 2018, 19(11): 3342

[3] CatalanoPM. Trying to understand gestational diabetes. Diabet Med, 2014, 31(3): 273-281

[4] ZhangE, GuoQ, GaoH, et al.. Metformin and Resveratrol Inhibited High Glucose-Induced Metabolic Memory of Endothelial Senescence through SIRT1/p300/p53/p21 Pathway. PLoS One, 2015, 10(12): e0143814

[5] IntineRV, SarrasMPJr. Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms. Curr Diab Rep, 2012, 12(5): 551-559

[6] KungJT, ColognoriD, LeeJT. Long noncoding RNAs: past, present, and future. Genetics, 2013, 193(3): 651-669

[7] GoyalN, KesharwaniD, DattaM. Lnc-ing non-coding RNAs with metabolism and diabetes: roles of lncRNAs. Cell Mol Life Sci, 2018, 75(10): 1827-1837

[8] FengSD, YangJH, YaoCH, et al.. Potential regulatory mechanisms of lncRNAin diabetes and its complications. Biochem Cell Biol, 2017, 95(3): 361-367

[9] RashidmayvanM, SahebiR, Ghayour-MobarhanM. Long non-coding RNAs: a valuable biomarker for metabolic syndrome. Mol Genet Genomics, 2022, 297(5): 1169-1183

[10] HuangC, HuangBB, NiuJM, et al.. Global mRNA and Long Non-Coding RNA Expression in the Placenta and White Adipose Tissue of Mice Fed a High-Fat Diet During Pregnancy. Cell Physiol Biochem, 2018, 50(6): 2260-2271

[11] LuJ, WuJ, ZhaoZ, et al.. Circulating LncRNA Serve as Fingerprint for Gestational Diabetes Mellitus Associated with Risk of Macrosomia. Cell Physiol Biochem, 2018, 48(3): 1012-1018

[12] SaeidiL, GhaediH, SadataminiM, et al.. Long non-coding RNA LY86-AS1 and HCG27_201 expression in type 2 diabetes mellitus. Mol Biol Rep, 2018, 45(6): 2601-2608

[13] SalehAA, KasemHE, ZahranES, et al.. Cell-free long non-coding RNAs (LY86-AS1 & HCG27_201and GAS5) as biomarkers for pre-diabetes and type 2 DM in Egypt. Biochem Biophys Rep, 2020, 23: 100770

[14] LengL, ZhangC, RenL, et al.. Construction of a long noncoding RNA-mediated competitive endogenous RNA network reveals global patterns and regulatory markers in gestational diabetes. Int J Mol Med, 2019, 43(2): 927-935

[15] PoirierC, DesgagneV, GuerinR, et al.. MicroRNAs in Pregnancy and Gestational Diabetes Mellitus: Emerging Role in Maternal Metabolic Regulation. Curr Diab Rep, 2017, 17(5): 35

[16] LiY, JiangJ, LiuW, et al.. microRNA-378 promotes autophagy and inhibits apoptosis in skeletal muscle. Proc Natl Acad Sci U S A, 2018, 115(46): E10849-E10858

[17] ChoiH, KohHWL, ZhouL, et al.. Plasma Protein and MicroRNA Biomarkers of Insulin Resistance: A Network-Based Integrative -Omics Analysis. Front Physiol, 2019, 10: 379

[18] ZhangY, LiC, LiH, et al.. miR-378 Activates the Pyruvate-PEP Futile Cycle and Enhances Lipolysis to Ameliorate Obesity in Mice. EBioMedicine, 2016, 5: 93-104

[19] ImperialR, ToorOM, HussainA, et al.. Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications. Semin Cancer Biol, 2019, 54: 14-28

[20] SalomonC, WestermeierF, PueblaC, et al.. Gestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin. PLoS One, 2012, 7(7): e40578

[21] XuZH, YaoTZ, LiuW. miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2. Biomed Pharmacother, 2018, 107: 1410-1417

[22] CaiM, KolluruGK, AhmedA. Small Molecule, Big Prospects: MicroRNA in Pregnancy and Its Complications. J Pregnancy, 2017, 2017: 6972732

[23] ZhaoC, ZhangT, ShiZ, et al.. MicroRNA-518d regulates PPARalpha protein expression in the placentas of females with gestational diabetes mellitus. Mol Med Rep, 2014, 9(6): 2085-2090

[24] CaoJL, ZhangL, LiJ, et al.. Up-regulation of miR-98 and unraveling regulatory mechanisms in gestational diabetes mellitus. Sci Rep, 2016, 6: 32268

[25] HolmanRR, PaulSK, BethelMA, et al.. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008, 359(15): 1577-1589

[26] HaywardRA, ReavenPD, WiitalaWL, et al.. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med, 2015, 372(23): 2197-2206

[27] JohansenMY, MacDonaldCS, HansenKB, et al.. Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial. JAMA, 2017, 318(7): 637-646